Immunotherapy has been approved to treat many tumor types. However, one characteristic of this therapeutic class is that survival benefit is due to late immune response, which leads to a delayed ...

In the midst of an increasing trend toward setting and meeting aggressive sustainability targets, organizations are scrambling to navigate the complex challenge of quantifying their impacts, and ...